Delivery Order SPE2DB24D8003-SPE2DB25FJTFA

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTFA
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, which is not set aside, has a ceiling value of $2,980.06 and a period of performance through October 29, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, allowing the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This recent delivery order award demonstrates Dakota Drug, Inc.'s position as a key strategic supplier for the Defense Logistics Agency's medical supply chain needs.

Generated 2/2/25, 12:05 AM